Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 18 publications
Overcoming Barriers to Developing and Implementing Novel Therapies for Hypertension.
Journal: Hypertension (Dallas, Tex. : 1979)
Published: August 28, 2025
Vutrisiran in Patients with Transthyretin Amyloidosis with Cardiomyopathy.
Journal: The New England journal of medicine
Published: August 30, 2024
Patisiran Treatment in Patients with Transthyretin Cardiac Amyloidosis.
Journal: The New England journal of medicine
Published: October 27, 2023
Lumasiran, an RNAi Therapeutic for Primary Hyperoxaluria Type 1.
Journal: The New England journal of medicine
Published: March 31, 2021
Phase 1/2 Study of Lumasiran for Treatment of Primary Hyperoxaluria Type 1: A Placebo-Controlled Randomized Clinical Trial.
Journal: Clinical journal of the American Society of Nephrology : CJASN
Published: September 11, 2020
Correction to: Phase 3 Multicenter Study of Revusiran in Patients with Hereditary Transthyretin-Mediated (hATTR) Amyloidosis with Cardiomyopathy (ENDEAVOUR).
Journal: Cardiovascular drugs and therapy
Published: June 18, 2020
Phase 3 Trial of RNAi Therapeutic Givosiran for Acute Intermittent Porphyria.
Journal: The New England journal of medicine
Published: June 11, 2020
Phase 3 Multicenter Study of Revusiran in Patients with Hereditary Transthyretin-Mediated (hATTR) Amyloidosis with Cardiomyopathy (ENDEAVOUR).
Journal: Cardiovascular drugs and therapy
Published: February 17, 2020
In-depth characterization of polyolefin plastomers/elastomers (ethylene/1-octene copolymers) through hyphenated chromatographic techniques.
Journal: Journal of chromatography. A
Published: January 21, 2020
Single-Dose Pharmacokinetics and Pharmacodynamics of Transthyretin Targeting N-acetylgalactosamine-Small Interfering Ribonucleic Acid Conjugate, Vutrisiran, in Healthy Subjects.
Journal: Clinical pharmacology and therapeutics
Published: December 26, 2019
Phase 1 Trial of an RNA Interference Therapy for Acute Intermittent Porphyria.
Journal: The New England journal of medicine
Published: February 07, 2019
Last Updated: 09/26/2026